chr1-40988656-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001905.4(CTPS1):c.501A>G(p.Gln167Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0172 in 1,614,002 control chromosomes in the GnomAD database, including 628 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 62 hom., cov: 32)
Exomes 𝑓: 0.017 ( 566 hom. )
Consequence
CTPS1
NM_001905.4 synonymous
NM_001905.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.742
Publications
10 publications found
Genes affected
CTPS1 (HGNC:2519): (CTP synthase 1) This gene encodes an enzyme responsible for the catalytic conversion of UTP (uridine triphosphate) to CTP (cytidine triphospate). This reaction is an important step in the biosynthesis of phospholipids and nucleic acids. Activity of this proten is important in the immune system, and loss of function of this gene has been associated with immunodeficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
CTPS1 Gene-Disease associations (from GenCC):
- severe combined immunodeficiency due to CTPS1 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 1-40988656-A-G is Benign according to our data. Variant chr1-40988656-A-G is described in ClinVar as Benign. ClinVar VariationId is 475187.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.742 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0852 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0220 AC: 3354AN: 152166Hom.: 64 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3354
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0254 AC: 6387AN: 251454 AF XY: 0.0269 show subpopulations
GnomAD2 exomes
AF:
AC:
6387
AN:
251454
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0167 AC: 24433AN: 1461716Hom.: 566 Cov.: 30 AF XY: 0.0183 AC XY: 13283AN XY: 727162 show subpopulations
GnomAD4 exome
AF:
AC:
24433
AN:
1461716
Hom.:
Cov.:
30
AF XY:
AC XY:
13283
AN XY:
727162
show subpopulations
African (AFR)
AF:
AC:
1334
AN:
33472
American (AMR)
AF:
AC:
378
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
570
AN:
26120
East Asian (EAS)
AF:
AC:
3926
AN:
39690
South Asian (SAS)
AF:
AC:
5684
AN:
86232
European-Finnish (FIN)
AF:
AC:
362
AN:
53418
Middle Eastern (MID)
AF:
AC:
245
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
10654
AN:
1111902
Other (OTH)
AF:
AC:
1280
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1075
2151
3226
4302
5377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0220 AC: 3356AN: 152286Hom.: 62 Cov.: 32 AF XY: 0.0232 AC XY: 1729AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
3356
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
1729
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
1493
AN:
41554
American (AMR)
AF:
AC:
179
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
70
AN:
3470
East Asian (EAS)
AF:
AC:
476
AN:
5174
South Asian (SAS)
AF:
AC:
324
AN:
4822
European-Finnish (FIN)
AF:
AC:
77
AN:
10616
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
669
AN:
68024
Other (OTH)
AF:
AC:
56
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
159
318
478
637
796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
272
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Severe combined immunodeficiency due to CTPS1 deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.